Budding of a Retrovirus: Some Assemblies Required
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 32 of the 65 sources its claims cite were checked for support.
Abstract
One of the most important steps in any viral lifecycle is the production of progeny virions. For retroviruses as well as other viruses, this step is a highly organized process that occurs with exquisite spatial and temporal specificity on the cellular plasma membrane. To facilitate this process, retroviruses encode short peptide motifs, or L domains, that hijack host factors to ensure completion of this critical step. One such cellular machinery targeted by viruses is known as the Endosomal Sorting Complex Required for Transport (ESCRTs). Typically responsible for vesicular trafficking within the cell, ESCRTs are co-opted by the retroviral Gag polyprotein to assist in viral particle assembly and release of infectious virions. This review in the Viruses Special Issue "The 11th International Retroviral Nucleocapsid and Assembly Symposium", details recent findings that shed light on the molecular details of how ESCRTs and the ESCRT adaptor protein ALIX, facilitate retroviral dissemination at sites of viral assembly.
Overview
CoChat Summary
## TL;DR
This review argues that retroviral budding depends on higher-order helical assemblies of host ESCRT machinery, especially ESCRT-I and ALIX, to support membrane scission and virion maturation. It synthesizes structural and mutational findings showing that disrupting these assemblies impairs virus release, Gag processing, and infectious particle production.
## Key findings
- HIV Gag uses two C-terminal late (L) domains, PTAP and LYPXnL, to recruit TSG101 and ALIX, respectively; in Jurkat and CEM cells, PTAP- or LYPXnL-mutant HIV showed about 33% and 50% reductions in virus release, while the double mutant reduced release by more than 80%.
- ESCRT-I forms higher-order helical assemblies, and a conserved VPS28 motif, 54EKAYIKD60, was reported as essential for ESCRT-I assembly; alanine scanning of this motif abolished release of genomic RNP-containing virus, and the VPS28 TM mutant failed to release NC in virus particles.
- ALIX Bro1-domain multimerization depends on the 317FIYHDR321 motif; mutating the 317FIY319 region caused severe budding defects, with “no detectable release of mature virus” for PTAP- HIV and similarly severe defects in EIAV.
- The authors propose that ESCRT-I and ALIX form a discontinuous co-polymer at budding sites that scaffolds nascent virions and templates ESCRT-III polymerization for membrane scission.
## Methods
- This is a review article synthesizing recent structural, biochemical, microscopy, and mutational studies on retroviral assembly and budding.
- The paper summarizes evidence from X-ray crystallography, negative-stain electron microscopy, super-resolution microscopy, tomography, and molecular modeling of ESCRT-I and ALIX assemblies.
- It also discusses structure-guided mutagenesis/alanine scanning studies of VPS28 and ALIX motifs and their effects on virus release and Gag processing.
## Limitations
- The paper states that the precise nature of host factors at the budding virion-cytoplasm boundary is yet to be determined, “perhaps due to its ephemeral nature.”
- It also notes that the precise molecular details underlying the role of NC in recruitment and/or function of host factors remains unclear; this is explicitly stated in the text.
- Evident from the text: many of the central results are attributed to “recent findings” or studies “submitted for review” / “manuscript in preparation,” so the review is synthesizing a still-evolving evidence base rather than reporting a single completed dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 ESCRT-I and ALIX helical assemblies are required for retroviral budding. Crystal structures of human ESCRT-I revealed that the hetero-tetramer core forms filaments mediated principally by contacts within VPS28. (A) Filament of human ESCRT-I as determined by X-ray crystallography. VPS28 is colored in beige, TSG101 in blue, VPS37 in pink, and MVB12 in red. Two views of the filament are shown for comparison of the helical and luminal parameters. Inset reveals VPS28 residues essential for filament formation colored in green. (B) Filament of the yeast ESCRT-I derived from a crystal (Teo et al., [21]). The individual yeast components are colored the same way as in (A) with the exception of MVB12 due to its absence in yeast. Note that the yeast filament adopts a one-start helix and a larger luminal width than that of human ESCRT-I which is a tighter three-start helix. (C) Lemniscate helix of Bro-1-domain protein Brox in the presence of a CHMP4B peptide (yellow). Brox is shown in beige with the FIY motif colored in pink at each interface (Mu et al., [35]). (D) Molecular modeling derived from the study by Rose et al. (submitted for review) of the yeast-derived human ESCRT-I complex bound to Gag. ESCRT-I components are colored in the same fashion as above and Gag is shown with CA in blue, NC in green, and p6 in orange. The VPS28 multimerization domain is highlighted in light green. (E) Luminal view of the molecular model for an ideal full-length ALIX helical assembly bound to Gag. ALIX is shown in grey with its Bro1 multimerization domain in pink. The CHMP4B peptide can be seen between ALIX dimers in gold. Due to differences in length between ALIX and ESCRT-I, the ALIX oligomer adopts a wider luminal width and larger helical repeat (18 copies of ALIX per turn versus 12 for ESCRT-I) in order to accommodate the diameter of assembling retroviral particles.](https://figures.cochat.ai/paper-figures/417765495fcc49849c880734a18b0098/budding-of-a-retrovirus-some-assemblies-required-figure-1.jpg)

Verification
Claims the paper makes
21 Valid · 2 Not valid · 10 Not checked · 18 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“cytokinesis, a process that displays many parallels with retroviral budding, depends on cooperativity between both TSG101 and ALIX”
§ Budding of a Retrovirus: Some Assemblies Required > 1. Introduction > The Role of Viral L Domains and Host Factors in Virus Assembly During the final stages of enveloped virus replication, viral proteins are co-assembled with their corresponding viral genome into a heterogeneous ribonucleoprotein complex (RNP). These RNPs are assembled at productive sites of virus release through interactions with many host cell co-factors including the Endosomal Sorting Complex Required for Transport (ESCRT) machinery, with a fraction of these components detected within infectious virions [1,2,3,4]. In order to efficiently transmit the genomic RNP packaged into nascent virions, the Human Immunodeficiency Virus (HIV), as well as other retroviruses, have evolved to encode multiple Late Budding (L) domains within their Gag proteins that recruit specific cellular factors to facilitate release and in turn virus spread. For HIV, the Gag protein encodes two C-terminal L domains with the highly conserved sequences PTAP and LYPXnL, that recruit the ESCRT-I component TSG101 and the ESCRT-I adapter protein, ALIX, respectively [5,6,7,8]. Additionally, some viruses encode just one L domain like the LYPXnL-encoding p9 protein of Equine Infectious Anemia Virus (EIAV) [9]. These two types of L domains and their cognate cellular partners operate in distinct cellular pathways to support vesicular trafficking and therefore independent mechanisms of virus release because abrogation of either individual sequence within HIV Gag still results in infectious particle release, albeit at significantly reduced levels [10,11]. More importantly, L domain deletion displays a compounding negative effect on virus release. In Jurkat and CEM cells, a physiologically relevant T cell system, PTAP (PTAP-) or LYPXnL (YP-) L domain mutant HIV exhibit reductions in virus release of approximately 33 and 50 percent, respectively, while a co-L domain deletion (PTAP-/YP-) showed the greatest release defect of more than 80 percent [12]. In parallel, it was recently shown that cytokinesis, a process that displays many parallels with retroviral budding, depends on cooperativity between both TSG101 and ALIX, potentiating a heterogeneous complex that may be ideal for retrovirus budding, as well as other cellular process, when possible [13]. Both processes of retroviral budding and cytokinesis culminate with a topologically similar membrane abscission process that separates progeny virions from host cell membranes and daughter cells from one another after cell division [13,14,15]. This final event is carried out by the ESCRT-III membrane scission machinery that is recruited by ALIX and ESCRT-I to these scission sites (for review, see [16]). However, this comparison between membrane sealing events also reveals a critical gap in our understanding of ESCRT-III recruitment to these sites. Indeed, the loss of ALIX recruitment to viral budding sites through HIV L domain deletion or to cytokinetic bridges via cellular depletion by RNA interference (RNAi) impairs but does not terminate these events. This mandates the presence of redundant and parallel ESCRT-III recruiting axes perhaps fulfilled by the intermediary ESCRT-II complex [13,17,18] or additional ALIX homologs and orthologs [19,20,21]. Despite their evolutionary conservation between viruses, these short L domain peptide motifs are not the sole determinants of cellular factor recruitment. Recently, it was shown that HIV Gag and other retroviruses are modified with ubiquitin in their p6 domains, and a C-terminal ubiquitin-Gag fusion construct mimicking a true p6 domain modification, can stimulate and rescue defective virus release [22,23]. The N-terminus of TSG101 contains a ubiquitin binding (UEV) domain that is essential for the recognition of Gag via its PTAP sequence, as well as ubiquitinated cargo for multivesicular trafficking, suggesting a functional role for viral Gag ubiquitination [5]. In addition to ubiquitin modification, the Nucleocapsid (NC) region of Gag has been implicated in binding to the Bro1 domain of ALIX, but also in binding to TSG101 [24,25,26,27]. However, the precise molecular details underlying the role of NC in the recruitment and/or the function of these host factors remains unclear, but these interactions are complex and may involve simultaneous binding to RNA [26].
What the sources say
- Supportedcites [13] Christ, 2016, ALIX and ESCRT-I/II function as parallel ESCRT-III recruiters in cytokinetic abscission, J. Cell Boil. source
The Results section, “Relation between CHMP4B midbody recruitment and abscission timing” (page not provided), reports that codepleting ALIX and TSG101 synergistically delayed cytokinetic abscission. The authors describe their roles in abscission as partially redundant, supporting the claim of cooperativity. (LLM, conf=0.91)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“abrogation of either individual sequence within HIV Gag still results in infectious particle release, albeit at significantly reduced levels [10,11].”
§ Budding of a Retrovirus: Some Assemblies Required > 1. Introduction > The Role of Viral L Domains and Host Factors in Virus Assembly During the final stages of enveloped virus replication, viral proteins are co-assembled with their corresponding viral genome into a heterogeneous ribonucleoprotein complex (RNP). These RNPs are assembled at productive sites of virus release through interactions with many host cell co-factors including the Endosomal Sorting Complex Required for Transport (ESCRT) machinery, with a fraction of these components detected within infectious virions [1,2,3,4]. In order to efficiently transmit the genomic RNP packaged into nascent virions, the Human Immunodeficiency Virus (HIV), as well as other retroviruses, have evolved to encode multiple Late Budding (L) domains within their Gag proteins that recruit specific cellular factors to facilitate release and in turn virus spread. For HIV, the Gag protein encodes two C-terminal L domains with the highly conserved sequences PTAP and LYPXnL, that recruit the ESCRT-I component TSG101 and the ESCRT-I adapter protein, ALIX, respectively [5,6,7,8]. Additionally, some viruses encode just one L domain like the LYPXnL-encoding p9 protein of Equine Infectious Anemia Virus (EIAV) [9]. These two types of L domains and their cognate cellular partners operate in distinct cellular pathways to support vesicular trafficking and therefore independent mechanisms of virus release because abrogation of either individual sequence within HIV Gag still results in infectious particle release, albeit at significantly reduced levels [10,11]. More importantly, L domain deletion displays a compounding negative effect on virus release. In Jurkat and CEM cells, a physiologically relevant T cell system, PTAP (PTAP-) or LYPXnL (YP-) L domain mutant HIV exhibit reductions in virus release of approximately 33 and 50 percent, respectively, while a co-L domain deletion (PTAP-/YP-) showed the greatest release defect of more than 80 percent [12]. In parallel, it was recently shown that cytokinesis, a process that displays many parallels with retroviral budding, depends on cooperativity between both TSG101 and ALIX, potentiating a heterogeneous complex that may be ideal for retrovirus budding, as well as other cellular process, when possible [13]. Both processes of retroviral budding and cytokinesis culminate with a topologically similar membrane abscission process that separates progeny virions from host cell membranes and daughter cells from one another after cell division [13,14,15]. This final event is carried out by the ESCRT-III membrane scission machinery that is recruited by ALIX and ESCRT-I to these scission sites (for review, see [16]). However, this comparison between membrane sealing events also reveals a critical gap in our understanding of ESCRT-III recruitment to these sites. Indeed, the loss of ALIX recruitment to viral budding sites through HIV L domain deletion or to cytokinetic bridges via cellular depletion by RNA interference (RNAi) impairs but does not terminate these events. This mandates the presence of redundant and parallel ESCRT-III recruiting axes perhaps fulfilled by the intermediary ESCRT-II complex [13,17,18] or additional ALIX homologs and orthologs [19,20,21]. Despite their evolutionary conservation between viruses, these short L domain peptide motifs are not the sole determinants of cellular factor recruitment. Recently, it was shown that HIV Gag and other retroviruses are modified with ubiquitin in their p6 domains, and a C-terminal ubiquitin-Gag fusion construct mimicking a true p6 domain modification, can stimulate and rescue defective virus release [22,23]. The N-terminus of TSG101 contains a ubiquitin binding (UEV) domain that is essential for the recognition of Gag via its PTAP sequence, as well as ubiquitinated cargo for multivesicular trafficking, suggesting a functional role for viral Gag ubiquitination [5]. In addition to ubiquitin modification, the Nucleocapsid (NC) region of Gag has been implicated in binding to the Bro1 domain of ALIX, but also in binding to TSG101 [24,25,26,27]. However, the precise molecular details underlying the role of NC in the recruitment and/or the function of these host factors remains unclear, but these interactions are complex and may involve simultaneous binding to RNA [26].
What the sources say
- Not checked — no full text of the sourcecites [10] Huang, 1995, p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease, J. Virol. source
- Partly supportedcites [11] Usami, 2007, Potent Rescue of Human Immunodeficiency Virus Type 1 Late Domain Mutants by ALIX/AIP1 Depends on Its CHMP4 Binding Site, J. Virol. sourceExperimental — accuracy not yet measured
The Results (page not provided) say Jurkat cells are partially permissive for viruses with either the Tsg101 or the ALIX binding site mutated, and report a severe particle-release defect for a PTAPP mutant in adherent cells. The Discussion (page not provided) says the ALIX binding site is less critical for release and/or infectivity than the Tsg101 site. These passages do not establish that mutation of either site significantly reduces the release of infectious particles. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“the loss of ALIX recruitment to viral budding sites through HIV L domain deletion or to cytokinetic bridges via cellular depletion by RNA interference (RNAi) impairs but does not terminate these events.”
§ Budding of a Retrovirus: Some Assemblies Required > 1. Introduction > The Role of Viral L Domains and Host Factors in Virus Assembly During the final stages of enveloped virus replication, viral proteins are co-assembled with their corresponding viral genome into a heterogeneous ribonucleoprotein complex (RNP). These RNPs are assembled at productive sites of virus release through interactions with many host cell co-factors including the Endosomal Sorting Complex Required for Transport (ESCRT) machinery, with a fraction of these components detected within infectious virions [1,2,3,4]. In order to efficiently transmit the genomic RNP packaged into nascent virions, the Human Immunodeficiency Virus (HIV), as well as other retroviruses, have evolved to encode multiple Late Budding (L) domains within their Gag proteins that recruit specific cellular factors to facilitate release and in turn virus spread. For HIV, the Gag protein encodes two C-terminal L domains with the highly conserved sequences PTAP and LYPXnL, that recruit the ESCRT-I component TSG101 and the ESCRT-I adapter protein, ALIX, respectively [5,6,7,8]. Additionally, some viruses encode just one L domain like the LYPXnL-encoding p9 protein of Equine Infectious Anemia Virus (EIAV) [9]. These two types of L domains and their cognate cellular partners operate in distinct cellular pathways to support vesicular trafficking and therefore independent mechanisms of virus release because abrogation of either individual sequence within HIV Gag still results in infectious particle release, albeit at significantly reduced levels [10,11]. More importantly, L domain deletion displays a compounding negative effect on virus release. In Jurkat and CEM cells, a physiologically relevant T cell system, PTAP (PTAP-) or LYPXnL (YP-) L domain mutant HIV exhibit reductions in virus release of approximately 33 and 50 percent, respectively, while a co-L domain deletion (PTAP-/YP-) showed the greatest release defect of more than 80 percent [12]. In parallel, it was recently shown that cytokinesis, a process that displays many parallels with retroviral budding, depends on cooperativity between both TSG101 and ALIX, potentiating a heterogeneous complex that may be ideal for retrovirus budding, as well as other cellular process, when possible [13]. Both processes of retroviral budding and cytokinesis culminate with a topologically similar membrane abscission process that separates progeny virions from host cell membranes and daughter cells from one another after cell division [13,14,15]. This final event is carried out by the ESCRT-III membrane scission machinery that is recruited by ALIX and ESCRT-I to these scission sites (for review, see [16]). However, this comparison between membrane sealing events also reveals a critical gap in our understanding of ESCRT-III recruitment to these sites. Indeed, the loss of ALIX recruitment to viral budding sites through HIV L domain deletion or to cytokinetic bridges via cellular depletion by RNA interference (RNAi) impairs but does not terminate these events. This mandates the presence of redundant and parallel ESCRT-III recruiting axes perhaps fulfilled by the intermediary ESCRT-II complex [13,17,18] or additional ALIX homologs and orthologs [19,20,21]. Despite their evolutionary conservation between viruses, these short L domain peptide motifs are not the sole determinants of cellular factor recruitment. Recently, it was shown that HIV Gag and other retroviruses are modified with ubiquitin in their p6 domains, and a C-terminal ubiquitin-Gag fusion construct mimicking a true p6 domain modification, can stimulate and rescue defective virus release [22,23]. The N-terminus of TSG101 contains a ubiquitin binding (UEV) domain that is essential for the recognition of Gag via its PTAP sequence, as well as ubiquitinated cargo for multivesicular trafficking, suggesting a functional role for viral Gag ubiquitination [5]. In addition to ubiquitin modification, the Nucleocapsid (NC) region of Gag has been implicated in binding to the Bro1 domain of ALIX, but also in binding to TSG101 [24,25,26,27]. However, the precise molecular details underlying the role of NC in the recruitment and/or the function of these host factors remains unclear, but these interactions are complex and may involve simultaneous binding to RNA [26].
What the sources say
- Partly supportedcites [13] Christ, 2016, ALIX and ESCRT-I/II function as parallel ESCRT-III recruiters in cytokinetic abscission, J. Cell Boil. sourceExperimental — accuracy not yet measured
The Results section, “Relation between CHMP4B midbody recruitment and abscission timing” (page unavailable), reports that ALIX knockdown delayed cytokinetic abscission but did not prevent the measured cells from reaching it. The paper does not report whether deleting the HIV L domain impairs viral budding without terminating it, so the viral-budding part is unsupported by our copy. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [17] Langelier, 2006, Human ESCRT-II Complex and Its Role in Human Immunodeficiency Virus Type 1 Release, J. Virol. source
- Partly supportedcites [18] Meng, 2015, Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) production, Retrovirology sourceExperimental — accuracy not yet measured
The Background identifies the YPXL motif as the route by which HIV-1 Gag recruits ALIX, and the Results (‘Knockdown of ESCRT-II has an additive effect on release of YPXL mutant virus’; page unavailable) report reduced, rather than abolished, virion export after YPXL mutation. Our copy does not report ALIX depletion by RNAi at cytokinetic bridges or its effect on cytokinesis; its discussion of cytokinesis concerns ESCRT-II. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Both processes of retroviral budding and cytokinesis culminate with a topologically similar membrane abscission process that separates progeny virions from host cell membranes and daughter cells from one another after cell division [13,14,15].”
§ Budding of a Retrovirus: Some Assemblies Required > 1. Introduction > The Role of Viral L Domains and Host Factors in Virus Assembly During the final stages of enveloped virus replication, viral proteins are co-assembled with their corresponding viral genome into a heterogeneous ribonucleoprotein complex (RNP). These RNPs are assembled at productive sites of virus release through interactions with many host cell co-factors including the Endosomal Sorting Complex Required for Transport (ESCRT) machinery, with a fraction of these components detected within infectious virions [1,2,3,4]. In order to efficiently transmit the genomic RNP packaged into nascent virions, the Human Immunodeficiency Virus (HIV), as well as other retroviruses, have evolved to encode multiple Late Budding (L) domains within their Gag proteins that recruit specific cellular factors to facilitate release and in turn virus spread. For HIV, the Gag protein encodes two C-terminal L domains with the highly conserved sequences PTAP and LYPXnL, that recruit the ESCRT-I component TSG101 and the ESCRT-I adapter protein, ALIX, respectively [5,6,7,8]. Additionally, some viruses encode just one L domain like the LYPXnL-encoding p9 protein of Equine Infectious Anemia Virus (EIAV) [9]. These two types of L domains and their cognate cellular partners operate in distinct cellular pathways to support vesicular trafficking and therefore independent mechanisms of virus release because abrogation of either individual sequence within HIV Gag still results in infectious particle release, albeit at significantly reduced levels [10,11]. More importantly, L domain deletion displays a compounding negative effect on virus release. In Jurkat and CEM cells, a physiologically relevant T cell system, PTAP (PTAP-) or LYPXnL (YP-) L domain mutant HIV exhibit reductions in virus release of approximately 33 and 50 percent, respectively, while a co-L domain deletion (PTAP-/YP-) showed the greatest release defect of more than 80 percent [12]. In parallel, it was recently shown that cytokinesis, a process that displays many parallels with retroviral budding, depends on cooperativity between both TSG101 and ALIX, potentiating a heterogeneous complex that may be ideal for retrovirus budding, as well as other cellular process, when possible [13]. Both processes of retroviral budding and cytokinesis culminate with a topologically similar membrane abscission process that separates progeny virions from host cell membranes and daughter cells from one another after cell division [13,14,15]. This final event is carried out by the ESCRT-III membrane scission machinery that is recruited by ALIX and ESCRT-I to these scission sites (for review, see [16]). However, this comparison between membrane sealing events also reveals a critical gap in our understanding of ESCRT-III recruitment to these sites. Indeed, the loss of ALIX recruitment to viral budding sites through HIV L domain deletion or to cytokinetic bridges via cellular depletion by RNA interference (RNAi) impairs but does not terminate these events. This mandates the presence of redundant and parallel ESCRT-III recruiting axes perhaps fulfilled by the intermediary ESCRT-II complex [13,17,18] or additional ALIX homologs and orthologs [19,20,21]. Despite their evolutionary conservation between viruses, these short L domain peptide motifs are not the sole determinants of cellular factor recruitment. Recently, it was shown that HIV Gag and other retroviruses are modified with ubiquitin in their p6 domains, and a C-terminal ubiquitin-Gag fusion construct mimicking a true p6 domain modification, can stimulate and rescue defective virus release [22,23]. The N-terminus of TSG101 contains a ubiquitin binding (UEV) domain that is essential for the recognition of Gag via its PTAP sequence, as well as ubiquitinated cargo for multivesicular trafficking, suggesting a functional role for viral Gag ubiquitination [5]. In addition to ubiquitin modification, the Nucleocapsid (NC) region of Gag has been implicated in binding to the Bro1 domain of ALIX, but also in binding to TSG101 [24,25,26,27]. However, the precise molecular details underlying the role of NC in the recruitment and/or the function of these host factors remains unclear, but these interactions are complex and may involve simultaneous binding to RNA [26].
What the sources say
- Supportedcites [13] Christ, 2016, ALIX and ESCRT-I/II function as parallel ESCRT-III recruiters in cytokinetic abscission, J. Cell Boil. source
The Introduction describes cytokinetic abscission and virus budding as topologically similar membrane scission events. It also defines abscission as cleavage of the membrane bridge connecting two daughter cells, supporting the comparison in the citing sentence. (LLM, conf=0.90)
- Supportedcites [14] Carlton, 2007, Parallels Between Cytokinesis and Retroviral Budding: A Role for the ESCRT Machinery, Science source
The abstract/description (p. 1) states that the abscission membrane fission event 'topologically resembles budding of viruses, such as HIV-1, from infected cells' and concludes that 'HIV-1 budding and cytokinesis use a similar subset of cellular components to carry out topologically similar membrane fission events.' The introduction (p. 1) supplies both halves of the claim's detail: cytokinesis 'requires the scission of a thin bridge of membrane connecting the daughter cells,' while retroviral L-domains mediate 'a membrane fission event that separates the nascent virion from the plasma membrane.' The paraphrase therefore matches what our copy says. (LLM, conf=0.92)
- Supportedcites [15] Cashikar, 2014, Structure of cellular ESCRT-III spirals and their relationship to HIV budding, eLife source
The Abstract describes viral budding and cytokinesis as topologically related processes involving membrane scission. The Introduction calls them topologically similar, and the Results and discussion describe scission as releasing a viral particle from the cell. The supplied passages do not give page numbers. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“This mandates the presence of redundant and parallel ESCRT-III recruiting axes perhaps fulfilled by the intermediary ESCRT-II complex [13,17,18] or additional ALIX homologs and orthologs [19,20,21].”
§ Budding of a Retrovirus: Some Assemblies Required > 1. Introduction > The Role of Viral L Domains and Host Factors in Virus Assembly During the final stages of enveloped virus replication, viral proteins are co-assembled with their corresponding viral genome into a heterogeneous ribonucleoprotein complex (RNP). These RNPs are assembled at productive sites of virus release through interactions with many host cell co-factors including the Endosomal Sorting Complex Required for Transport (ESCRT) machinery, with a fraction of these components detected within infectious virions [1,2,3,4]. In order to efficiently transmit the genomic RNP packaged into nascent virions, the Human Immunodeficiency Virus (HIV), as well as other retroviruses, have evolved to encode multiple Late Budding (L) domains within their Gag proteins that recruit specific cellular factors to facilitate release and in turn virus spread. For HIV, the Gag protein encodes two C-terminal L domains with the highly conserved sequences PTAP and LYPXnL, that recruit the ESCRT-I component TSG101 and the ESCRT-I adapter protein, ALIX, respectively [5,6,7,8]. Additionally, some viruses encode just one L domain like the LYPXnL-encoding p9 protein of Equine Infectious Anemia Virus (EIAV) [9]. These two types of L domains and their cognate cellular partners operate in distinct cellular pathways to support vesicular trafficking and therefore independent mechanisms of virus release because abrogation of either individual sequence within HIV Gag still results in infectious particle release, albeit at significantly reduced levels [10,11]. More importantly, L domain deletion displays a compounding negative effect on virus release. In Jurkat and CEM cells, a physiologically relevant T cell system, PTAP (PTAP-) or LYPXnL (YP-) L domain mutant HIV exhibit reductions in virus release of approximately 33 and 50 percent, respectively, while a co-L domain deletion (PTAP-/YP-) showed the greatest release defect of more than 80 percent [12]. In parallel, it was recently shown that cytokinesis, a process that displays many parallels with retroviral budding, depends on cooperativity between both TSG101 and ALIX, potentiating a heterogeneous complex that may be ideal for retrovirus budding, as well as other cellular process, when possible [13]. Both processes of retroviral budding and cytokinesis culminate with a topologically similar membrane abscission process that separates progeny virions from host cell membranes and daughter cells from one another after cell division [13,14,15]. This final event is carried out by the ESCRT-III membrane scission machinery that is recruited by ALIX and ESCRT-I to these scission sites (for review, see [16]). However, this comparison between membrane sealing events also reveals a critical gap in our understanding of ESCRT-III recruitment to these sites. Indeed, the loss of ALIX recruitment to viral budding sites through HIV L domain deletion or to cytokinetic bridges via cellular depletion by RNA interference (RNAi) impairs but does not terminate these events. This mandates the presence of redundant and parallel ESCRT-III recruiting axes perhaps fulfilled by the intermediary ESCRT-II complex [13,17,18] or additional ALIX homologs and orthologs [19,20,21]. Despite their evolutionary conservation between viruses, these short L domain peptide motifs are not the sole determinants of cellular factor recruitment. Recently, it was shown that HIV Gag and other retroviruses are modified with ubiquitin in their p6 domains, and a C-terminal ubiquitin-Gag fusion construct mimicking a true p6 domain modification, can stimulate and rescue defective virus release [22,23]. The N-terminus of TSG101 contains a ubiquitin binding (UEV) domain that is essential for the recognition of Gag via its PTAP sequence, as well as ubiquitinated cargo for multivesicular trafficking, suggesting a functional role for viral Gag ubiquitination [5]. In addition to ubiquitin modification, the Nucleocapsid (NC) region of Gag has been implicated in binding to the Bro1 domain of ALIX, but also in binding to TSG101 [24,25,26,27]. However, the precise molecular details underlying the role of NC in the recruitment and/or the function of these host factors remains unclear, but these interactions are complex and may involve simultaneous binding to RNA [26].
What the sources say
- Supportedcites [13] Christ, 2016, ALIX and ESCRT-I/II function as parallel ESCRT-III recruiters in cytokinetic abscission, J. Cell Boil. source
The Discussion concludes that CHMP4B is recruited through two parallel pathways during cytokinetic abscission: one via ALIX and the other via ESCRT-I–ESCRT-II–CHMP6. This supports the attributed point about parallel ESCRT-III recruitment axes. Page numbers are unavailable in our copy. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [17] Langelier, 2006, Human ESCRT-II Complex and Its Role in Human Immunodeficiency Virus Type 1 Release, J. Virol. source
- Supportedcites [18] Meng, 2015, Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) production, Retrovirology source
The Background (page not provided) describes two routes to ESCRT-III in HIV-1 budding: ALIX recruits CHMP4 directly, whereas ESCRT-I recruits it through ESCRT-II and CHMP6. The Results section on the YPXL mutant also calls ALIX an alternative pathway, supporting the cited point about parallel recruiting routes. The statement that this arrangement is ‘mandated’ is the citing authors’ inference. (LLM, conf=0.87)
- Supportedcites [19] Kim, 2005, Structural Basis for Endosomal Targeting by the Bro1 Domain, Dev. Cell source
The citation in the citing sentence attaches to the 'additional ALIX homologs and orthologs' clause, not to the citing authors' own inference that such axes are 'mandated'. Our copy of Kim et al. (2005) supplies exactly that: the Introduction states that Pfam lists 54 Bro1-domain proteins 'including Bro1, Alix, Rim20, Rhophilin, the protein tyrosine phosphatase HD-PTP, and Xp95, and their orthologs', of which Bro1, Alix and Rim20 'are known to associate with late endosomes and with ESCRT-III', and that the Snf7-binding hydrophobic patch 'is conserved in other Bro1 domain proteins, suggesting that this recruitment mechanism is a general property of Bro1 domains'. The Discussion closes by inferring that 'the Bro1 domain is a conserved ESCRT-III targeting domain'. Thus the source does support parallel/redundant Alix-homolog routes to ESCRT-III recruitment; the 'mandated' framing is the citing authors' own argument and is not attributable to this paper. (LLM, conf=0.80)
- Not checked — no full text of the sourcecites [20] Ichioka, 2008, Brox, a novel farnesylated Bro1 domain-containing protein that associates with charged multivesicular body protein 4 (CHMP4), FEBS J. source
- Supportedcites [21] Doyotte, 2008, The Bro1-related protein HD-PTP/PTPN23 is required for endosomal cargo sorting and multivesicular body morphogenesis, Proc. Natl. Acad. Sci. USA source
The Abstract (p. null) states that sorting of the Alix-binding p6-TfR-GFP chimera 'was not prevented by depleting Alix but instead required the Alix-related protein HD-PTP/PTPN23', and the Results and Discussion record that Alix depletion only modestly affected EGF trafficking, leading the authors to propose that 'other factors may account for the Bro1p-related activity at the endosome or at least compensate for the loss of Alix'. Our copy then shows HD-PTP binds ESCRT-III (CHMP4B) through its Bro1 domain, with 'ESCRT-III binding correlating with full biological activity' — i.e. an additional ALIX homolog/ortholog supplying a parallel Bro1-family ESCRT-III-recruiting route, exactly the example the citing sentence invokes (itself hedged with 'perhaps fulfilled by'). The only softness is that Doyotte et al. conclude ESCRT-III binding is 'important but not strictly essential' for HD-PTP function, so the paper supports the redundancy rather than asserting it as a formal mandate. (LLM, conf=0.82)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
16 more claims · 5 with their cited sources checked
Create a free account to see all 51 claims and to verify the 8 references still open.
- Probably not a substantial claim. 5
- It may state two separate claims as one. 26
- The quote only partly states this claim. 1
Citations
Cites
Vietri, M., Radulovic, M., & Stenmark, H. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0177-4 · Cited by 962 · cited 1×
“This final event is carried out by the ESCRT-III membrane scission machinery that is recruited by ALIX and ESCRT-I to these scission sites (for review, see [16]).”
BackgroundAIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding
Strack, B., Calistri, A., Craig, S., Popova, E., & Göttlinger, H. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00653-6 · Cited by 825
Mature HIV-1 capsid structure by cryo-electron microscopy and all-atom molecular dynamics
Zhao, G., Perilla, J. R., Yufenyuy, E. L., Meng, X., Chen, B., Ning, J., Ahn, J., Gronenborn, A. M., Schulten, K., Aiken, C., et al. (2013) · Nature · doi:10.1038/nature12162 · Cited by 801
Parallels Between Cytokinesis and Retroviral Budding: A Role for the ESCRT Machinery
Carlton, J. G., & Martin-Serrano, J. (2007) · Science · doi:10.1126/science.1143422 · Cited by 764
Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis
Morita, E., Sandrin, V., Chung, H., Morham, S. G., Gygi, S. P., Rodesch, C. K., & Sundquist, W. I. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601850 · Cited by 724
Martin-Serrano, J., Zang, T., & Bieniasz, P. D. (2001) · Nature Medicine · doi:10.1038/nm1201-1313 · Cited by 710
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55 Gag
VerPlank, L., Bouamr, F., LaGrassa, T. J., Agresta, B., Kikonyogo, A., Leis, J., & Carter, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131059198 · Cited by 584 · cited 1×
“The N-terminus of TSG101 contains a ubiquitin binding (UEV) domain that is essential for the recognition of Gag via its PTAP sequence, as well as ubiquitinated cargo for multivesicular trafficking, suggesting a functional role for viral Gag ubiquitination [5].”
BackgroundSelf-citationHuang, M., Orenstein, J. M., Martin, M. A., & Freed, E. O. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6810-6818.1995 · Cited by 486
An atomic model of HIV-1 capsid-SP1 reveals structures regulating assembly and maturation
Schur, F. K. M., Obr, M., Hagen, W. J. H., Wan, W., Jakobi, A. J., Kirkpatrick, J. M., Sachse, C., Kräusslich, H.-G., & Briggs, J. A. G. (2016) · Science · doi:10.1126/science.aaf9620 · Cited by 415
Wiegers, K., Rutter, G., Kottler, H., Tessmer, U., Hohenberg, H., & Kräusslich, H.-G. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2846-2854.1998 · Cited by 336
Cited by
The Role of Exosome and the ESCRT Pathway on Enveloped Virus Infection
Ju, Y., Bai, H., Ren, L., & Zhang, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169060 · Cited by 97
The Interplay between ESCRT and Viral Factors in the Enveloped Virus Life Cycle
Meng, B., & Lever, A. M. L. (2021) · Viruses · doi:10.3390/v13020324 · Cited by 64
“Other docking assemblies may exist [166].”
Why Cells and Viruses Cannot Survive without an ESCRT
Calistri, A., Reale, A., Palù, G., & Parolin, C. (2021) · Cells · doi:10.3390/cells10030483 · Cited by 55
“An updated review on this topic focused on retroviruses was recently published by Rose and coworkers [206], and several excellent and more general ones are available [12,18].”
BackgroundLerner, G., Weaver, N. C., Anokhin, B., & Spearman, P. W. (2022) · Viruses · doi:10.3390/v14030478 · Cited by 56
Importance of viral late domains in budding and release of enveloped RNA viruses
Welker, L., Paillart, J.-C., & Bernacchi, S. (2021) · Viruses · doi:10.3390/v13081559 · Cited by 36
Metadata
- Authors
- Rose, K. M., Hirsch, V. M., & Bouamr, F.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Bouamr, Fadila
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2020-10-20
- Volume
- 12
- Issue
- 10
- Pages
- 1188
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC7589157
- OpenAlex
- W3094626454
- Cited by
- 32
- References
- 55
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 6 · 2021: 12 · 2020: 1
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- NHLBI Division of Intramural Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- viral assembly, ESCRT, Alix, L-domains, Gag protein, plasma membrane, viral release, vesicle trafficking
- MeSH terms
- Retroviridae, Ribonucleoproteins, HIV-1, Virus Assembly, Nucleocapsid, gag Gene Products, Human Immunodeficiency Virus, Endosomal Sorting Complexes Required for Transport, Virus Release
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Budding of a Retrovirus: Some Assemblies Required. https://app.cochat.ai/papers/10.3390/v12101188
- The paper
- Rose, K. M., Hirsch, V. M., & Bouamr, F. (2020). Budding of a Retrovirus: Some Assemblies Required. Viruses. https://doi.org/10.3390/v12101188
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.